Medicare drug negotiations appear to be a long-term reality for the pharmaceutical industry. The negotiations may lead to price cuts for certain prescription drugs, although the impact on drug prices is uncertain, with some outlets suggesting prices may continue to rise. The scope of the negotiations is still taking shape, with additional drugs potentially being selected for price cuts in the future.